Clinical Care Network

All patients with juvenile myositis deserve the best care possible.

The Cure JM Clinical Care Network links patients to top physicians in the U.S. and globally who are actively pursuing better treatments and a cure for juvenile myositis.

Alexei Grom, M.D.

Alexei Grom, M.D.

Cincinnati Children’s Hospital Medical Center
Cincinnati, OH

Grom’s early work with outstanding mentors, who were pediatric rheumatologists, led him to pursue his clinical and research interests. During his fellowship, the unfortunate death of a patient from macrophage activation syndrome (MAS) prompted him to further study this life-threatening complication of systemic juvenile idiopathic arthritis.

Currently, he focuses on identifying risk factors and new therapeutic targets in MAS. Transnational studies have identified interferon gamma (INF), a dimerized soluble cytokine, as a therapeutic target in patients suffering from MAS. This discovery provided the rationale for a new clinical trial that is currently underway.

His research is funded by the National Institutes of Health (NIH) and the Systemic Juvenile Idiopathic Arthritis (SJIA) Foundation. He has also received research grants from Sobi, Novartis and AB2Bio.

Family Liaison(s):

Make an Appointment:

Interested in DIY fundraising but need help?

We’re here to help!

To have your fundraiser matched, add “DIY Match” in the memo of your online gift or check.